Technical Analysis for ITOS - iTeos Therapeutics, Inc.

Grade Last Price % Change Price Change
D 10.26 -5.09% -0.55
ITOS closed down 5.09 percent on Monday, March 18, 2024, on 62 percent of normal volume. The stock fell below its 50 day moving average, damaging its intermediate-term outlook by crossing under that important trendline. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
1 Watcher
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Down Down Down

Date Alert Name Type % Chg
Fell Below 50 DMA Bearish 0.00%
Stochastic Reached Oversold Weakness 0.00%
Oversold Stochastic Weakness 0.00%
Crossed Above 50 DMA Bullish -5.09%
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup -5.09%
NR7 Range Contraction -5.09%
Inside Day Range Contraction -5.09%
Fell Below 20 DMA Bearish -4.38%
Fell Below 50 DMA Bearish -4.38%
MACD Bearish Signal Line Cross Bearish -4.38%

   Recent Intraday Alerts

Alert Time
Down 5% about 14 hours ago
60 Minute Opening Range Breakdown about 15 hours ago
Down 3% about 20 hours ago
Fell Below 50 DMA about 20 hours ago
Fell Below Previous Day's Low about 20 hours ago

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Iteos Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of immuno-oncology therapeutics for cancer patients. Its product pipeline includes EOS-850, a small molecule antagonist of the adenosine A2a receptor; and EOS-448, an antagonist of TIGIT or T-cell immunoreceptor with Ig and ITIM domains. The company was founded in 2011 and is based in Cambridge, Massachusetts with an additional location in Gosselies, Belgium.
Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Biopharmaceutical Cancer Life Sciences Adenosine Therapeutics For Cancer

Is ITOS a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 18.24
52 Week Low 8.2
Average Volume 253,421
200-Day Moving Average 11.50
50-Day Moving Average 10.71
20-Day Moving Average 11.03
10-Day Moving Average 11.35
Average True Range 0.57
RSI (14) 42.86
ADX 17.43
+DI 18.60
-DI 25.30
Chandelier Exit (Long, 3 ATRs) 10.79
Chandelier Exit (Short, 3 ATRs) 11.41
Upper Bollinger Bands 12.23
Lower Bollinger Band 9.82
Percent B (%b) 0.18
BandWidth 21.89
MACD Line 0.12
MACD Signal Line 0.23
MACD Histogram -0.1101
Fundamentals Value
Market Cap 367.15 Million
Num Shares 35.8 Million
EPS -1.75
Price-to-Earnings (P/E) Ratio -5.86
Price-to-Sales 5.87
Price-to-Book 0.64
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 11.07
Resistance 3 (R3) 11.16 10.98 10.94
Resistance 2 (R2) 10.98 10.77 10.94 10.89
Resistance 1 (R1) 10.62 10.65 10.53 10.53 10.84
Pivot Point 10.44 10.44 10.40 10.40 10.44
Support 1 (S1) 10.08 10.23 9.99 9.99 9.68
Support 2 (S2) 9.90 10.11 9.86 9.63
Support 3 (S3) 9.54 9.90 9.59
Support 4 (S4) 9.45